Formosa Drug Patent Portfolio
Formosa owns 1 orange book drug protected by 2 US patents Given below is the list of Formosa's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10588913 | Aqueous suspension agent containing glucocorticosteroid nanoparticles | 09 May, 2036 | Active |
| US11376262 | Method of treating an inflammatory or infectious disease | 09 May, 2036 | Active |
Latest Legal Activities on Formosa's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Formosa.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 17 Mar, 2023 | US10588913 |
|
Recordation of Patent Grant Mailed
Critical
| 05 Jul, 2022 | US11376262 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 05 Jul, 2022 | US11376262 |
|
Email Notification
Critical
| 16 Jun, 2022 | US11376262 |
|
Issue Notification Mailed
Critical
| 15 Jun, 2022 | US11376262 |
| Dispatch to FDC | 25 May, 2022 | US11376262 |
|
Application Is Considered Ready for Issue
Critical
| 25 May, 2022 | US11376262 |
|
Issue Fee Payment Received
Critical
| 20 May, 2022 | US11376262 |
|
Issue Fee Payment Verified
Critical
| 08 May, 2022 | US11376262 |
|
Email Notification
Critical
| 08 Apr, 2022 | US11376262 |
|
Mail Response to 312 Amendment (PTO-271)
Critical
| 08 Apr, 2022 | US11376262 |
|
Response to Amendment under Rule 312
Critical
| 04 Apr, 2022 | US11376262 |
|
Pubs Case Remand to TC
Critical
| 17 Mar, 2022 | US11376262 |
|
Amendment after Notice of Allowance (Rule 312)
Critical
| 16 Mar, 2022 | US11376262 |
|
Email Notification
Critical
| 24 Feb, 2022 | US11376262 |
Formosa's Family Patents
Formosa Drug List
Given below is the complete list of Formosa's drugs and the patents protecting them.
1. Clobetasol Propionate
Clobetasol Propionate is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10588913 | Aqueous suspension agent containing glucocorticosteroid nanoparticles |
09 May, 2036
(11 years from now)
| Active |
| US11376262 | Method of treating an inflammatory or infectious disease |
09 May, 2036
(11 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Clobetasol Propionate's drug page